We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$884M
AUM Growth
+$6.79M
Cap. Flow
-$8.89M
Cap. Flow %
-1.01%
Top 10 Hldgs %
21.23%
Holding
269
New
8
Increased
62
Reduced
115
Closed
6

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.95M
2
AMZN icon
Amazon
AMZN
+$2.94M
3
TEL icon
TE Connectivity
TEL
+$2.39M
4
V icon
Visa
V
+$1.47M
5
AMT icon
American Tower
AMT
+$1M

Top Sells

Rank Stock Value
1
PH icon
Parker-Hannifin
PH
+$6.62M
2
ORCL icon
Oracle
ORCL
+$5.59M
3
MON
Monsanto Co
MON
+$2.64M
4
XOM icon
ExxonMobil
XOM
+$1.85M
5
GE icon
GE Aerospace
GE
+$1.45M

Sector Composition

Rank Sector Weight
1 Healthcare 16.41%
2 Technology 15.55%
3 Industrials 11.64%
4 Consumer Staples 8.49%
5 Financials 7.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPGI icon
51
S&P Global
SPGI
$121B
$5.83M 0.66%
28,580
– –
WY icon
52
Weyerhaeuser
WY
$18.6B
$5.63M 0.64%
154,303
-2,165
-1% -$79.2K
SLB icon
53
SLB Ltd
SLB
$74.1B
$5.55M 0.63%
82,878
-9,911
-11% -$681K
DHR icon
54
Danaher
DHR
$140B
$5.46M 0.62%
62,429
-350
-0.6% -$31.2K
ORCL icon
55
Oracle
ORCL
$416B
$5.44M 0.62%
123,461
-121,348
-50% -$5.59M
RTN
56
DELISTED
Raytheon Company
RTN
$5.29M 0.6%
27,377
+1,301
+5% +$273K
TMO icon
57
Thermo Fisher Scientific
TMO
$214B
$5.23M 0.59%
25,270
+1,297
+5% +$275K
LKQ icon
58
LKQ Corp
LKQ
$6.1B
$5.22M 0.59%
163,671
-1,361
-0.8% -$45.4K
CVX icon
59
Chevron
CVX
$366B
$5.16M 0.58%
40,776
-2,510
-6% -$312K
KMI icon
60
Kinder Morgan
KMI
$69.3B
$5.1M 0.58%
288,753
+1,057
+0.4% +$17.3K
IDXX icon
61
Idexx Laboratories
IDXX
$46.1B
$5.03M 0.57%
23,099
+1,005
+5% +$207K
PM icon
62
Philip Morris
PM
$294B
$4.62M 0.52%
57,265
-278
-0.5% -$23.6K
JPM icon
63
JPMorgan Chase
JPM
$955B
$4.55M 0.51%
43,641
+1,210
+3% +$133K
EEM icon
64
iShares MSCI Emerging Markets ETF
EEM
$29.5B
$4.45M 0.5%
102,582
-1,100
-1% -$50.9K
INTC icon
65
Intel
INTC
$510B
$4.36M 0.49%
87,713
-775
-0.9% -$41.2K
THO icon
66
Thor Industries
THO
$4.14B
$4.36M 0.49%
44,754
+80
+0.2% +$8.16K
EOG icon
67
EOG Resources
EOG
$70.4B
$4.15M 0.47%
33,352
– –
PFE icon
68
Pfizer
PFE
$147B
$4.11M 0.47%
119,464
-105
-0.1% -$3.59K
CSCO icon
69
Cisco
CSCO
$479B
$4.11M 0.47%
95,547
-880
-0.9% -$38.5K
LOW icon
70
Lowe's Companies
LOW
$123B
$3.9M 0.44%
40,849
-1,025
-2% -$92.8K
LECO icon
71
Lincoln Electric
LECO
$15.2B
$3.86M 0.44%
43,953
-551
-1% -$49.1K
NEOG icon
72
Neogen
NEOG
$2.49B
$3.72M 0.42%
92,850
-738
-0.8% -$27.2K
VEU icon
73
Vanguard FTSE All-World ex-US ETF
VEU
$68B
$3.71M 0.42%
71,542
+158
+0.2% +$8.56K
CLX icon
74
Clorox
CLX
$12.8B
$3.68M 0.42%
27,239
+500
+2% +$61.7K
MO icon
75
Altria Group
MO
$114B
$3.64M 0.41%
64,134
– –
1 2
3
4 5

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return

Boston Family Office's Q2 2018 Portfolio in Review

As of Q2 2018, Boston Family Office held 269 positions worth $884M, up 0.77% from $877M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q2 2018 filing shows 8 new, 62 increased, 115 reduced and 6 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 32,150 shares worth $3.06M. The largest sale was Parker-Hannifin, an estimated $6.62M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

  • Boston Family Office's largest Q2 2018 buy was State Street SPDR S&P Biotech ETF: 32,150 shares worth $3.06M.
  • Boston Family Office added most to Amazon in Q2 2018, an estimated $2.94M increase.
  • Boston Family Office's biggest Q2 2018 reduction was Parker-Hannifin, cutting an estimated $6.62M.
  • Boston Family Office fully exited Monsanto Co in Q2 2018, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $884M portfolio in Q2 2018.
  • Boston Family Office opened 8 new positions and closed 6 in Q2 2018.
  • Boston Family Office's portfolio value rose 0.77% quarter-over-quarter to $884M.

Based on Boston Family Office's 13F filing for Q2 2018, filed 26 Jul 2018.